Jane Street’s IceCure Medical ICCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,655
Closed -$66.9K 12202
2025
Q4
$66.9K Buy
+3,655
New +$82K ﹤0.01% 10391
2024
Q1
Sell
-531
Closed -$17K 9596
2023
Q4
$17K Buy
+531
New +$14.1K ﹤0.01% 8928
2022
Q1
Sell
-2,747
Closed -$249K 10618
2021
Q4
$249K Buy
2,747
+1,421
+107% +$237K ﹤0.01% 8483
2021
Q3
$348K Buy
+1,326
New +$393K ﹤0.01% 7907

Other funds holding ICCM

Jane Street's ICCM Position: Q1 2026 in Review

Jane Street sold out of IceCure Medical (ICCM) in Q1 2026, closing a stake of 3,655 shares — an estimated $66.9K sold.

Jane Street first reported a position in ICCM in Q3 2021 and held it in 4 quarters. The position peaked at $348K in Q3 2021. 17 funds tracked by Wall St. Rank hold ICCM as of Q1 2026.

  • Jane Street reported no remaining IceCure Medical position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 3,655 IceCure Medical shares in Q1 2026, an estimated $66.9K.
  • Jane Street first reported a position in IceCure Medical in Q3 2021 and held it in 4 quarters.
  • Jane Street's IceCure Medical position peaked at $348K in Q3 2021.
  • 17 funds tracked by Wall St. Rank held IceCure Medical as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.